Katy Drieu

Title: Katy Drieu: Innovator in Ginkgo Extract Applications

Introduction

Katy Drieu is a prominent inventor based in Paris, France. She has made significant contributions to the field of medicinal applications of Ginkgo extracts. With a total of 3 patents, her work focuses on innovative methods to combat cancer cell proliferation and assist individuals with substance dependencies.

Latest Patents

Drieu's latest patents include groundbreaking methods utilizing Ginkgo extract. One notable invention is directed towards the use of Ginkgo biloba leaves or isolated Ginkgolide B (GKB) to decrease the expression of peripheral-type benzodiazepine receptors in patients. This method aims to reduce the proliferation of cancer cells, particularly human breast cancer cells that exhibit aggressive and invasive phenotypes. Another significant patent involves the use of Ginkgo extracts in preparing medications to ease withdrawal symptoms for individuals dependent on substances such as alcohol, tobacco, and drugs.

Career Highlights

Throughout her career, Katy Drieu has worked with esteemed organizations, including Société de Conseils de Recherches et d'Applications Scientifiques (SCRAS). Her innovative research has positioned her as a key figure in the development of therapeutic applications derived from Ginkgo extracts.

Collaborations

Drieu has collaborated with notable professionals in her field, including Vassilios Papadopoulos. Their joint efforts have contributed to advancing research in the medicinal uses of Ginkgo.

Conclusion

Katy Drieu's work exemplifies the intersection of innovation and healthcare. Her patents reflect a commitment to improving patient outcomes through the application of Ginkgo extracts. Her contributions continue to inspire advancements in medicinal research and therapeutic solutions.